Alexander Denner, Director at Ariad, holds 5.66M shares in Innoviva (Ticker: INVA), holds 16.55M shares in Ironwood Pharma (Ticker: IRWD), holds 658.10K shares in Biogen (Ticker: BIIB). Most recently, Alexander Denner Sold ― shares of Innoviva on Mar 06, 2025 for an estimated value of 28.38M.
Alexander Denner latest transaction was an Informative Sell of $28.38M.
What was Alexander Denner's most profitable transaction?
Alexander Denner’s most profitable transaction was an Informative Buy of MDCO stock on December 21, 2018. The return on the trade was 390.50%.
What is Alexander Denner's role in Ariad?
Alexander Denner's role in Ariad is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.